公开(公告)号：US10808259B2

公开(公告)日：2020-10-20

申请号：US14112681

申请日：2012-04-19

Applicant: Anish Kaachra ,  Surender Kumar Vats ,  Paramvir Singh Ahuja ,  Sanjay Kumar

Inventor： Anish Kaachra ,  Surender Kumar Vats ,  Paramvir Singh Ahuja ,  Sanjay Kumar

IPC: C12N15/82

Abstract: The assimilated C and N largely influence plant growth and crop yields. Previous attempts to alter the carbon and nitrogen status of the plants attempted with one or two genes The present invention involves simultaneous co-overexpression of three genes wherein one gene (PEPCase) efficiently capture CO2 whereas the other two encode for enzymes (Asp AT and GS) involved in nitrogen assimilation. The combined effect is the enhancement of carbon and nitrogen status of the plant and the productivity.

公开(公告)号：US09563557B2

公开(公告)日：2017-02-07

申请号：US14580632

申请日：2014-12-23

Applicant: Sanjay Kumar ,  Rajesh M. Sankaran ,  Subramanya R. Dulloor ,  Andrew V. Anderson

Inventor： Sanjay Kumar ,  Rajesh M. Sankaran ,  Subramanya R. Dulloor ,  Andrew V. Anderson

IPC: G06F12/00 ,  G06F13/00 ,  G06F12/08

CPC classification number: G06F12/0804 ,  G06F9/467 ,  G06F11/07 ,  G06F11/073 ,  G06F11/0778 ,  G06F11/0793 ,  G06F11/14 ,  G06F11/1482 ,  G06F12/0868 ,  G06F2201/805 ,  G06F2201/82 ,  G06F2212/1032 ,  G06F2212/608

Abstract: A processor includes a memory management unit and a front end including a decoder. The decoder includes logic to receive a flush-on-commit (FoC) instruction to flush dirty data from a volatile cache to a persistent memory upon commitment of a store associated with the FoC instruction. The memory management unit includes logic to, based upon a flush-on-fail (FoF) mode, skip execution of the flush-on-commit instruction and to flush the dirty data from the volatile cache upon a subsequent FoF operation.

Abstract translation: 处理器包括存储器管理单元和包括解码器的前端。 解码器包括用于在与FoC指令相关联的存储的承诺时接收刷新提交（FoC）指令以将脏数据从易失性高速缓冲器刷新到持久存储器的逻辑。 存储器管理单元包括基于刷新失败（FoF）模式的逻辑，跳过刷新提交指令的执行，并且在随后的FoF操作时从易失性高速缓存清除脏数据。

公开(公告)号：US09471243B2

公开(公告)日：2016-10-18

申请号：US13327366

申请日：2011-12-15

Applicant: Sanjay Kumar ,  Venkatesha M. G.

Inventor： Sanjay Kumar ,  Venkatesha M. G.

IPC: G06F12/00 ,  G06F17/30 ,  G06F3/06

CPC classification number: G06F3/0649 ,  G06F3/0605 ,  G06F3/0685

Abstract: Various systems and methods for performing dynamic storage tiering in a virtual environment. For example, one method can involve identifying a location of a storage object within a virtual machine file, where the virtual machine file includes multiple storage objects. The method then involves detecting whether the storage object meets a criterion of a tiering policy. If the storage object meets the criterion, the storage object is moved from one tier of a multi-tier storage system to another tier of the multi-tier storage system.

Abstract translation: 用于在虚拟环境中执行动态存储分层的各种系统和方法。 例如，一种方法可以涉及识别虚拟机文件内的存储对象的位置，其中虚拟机文件包括多个存储对象。 该方法然后涉及检测存储对象是否满足分层策略的标准。 如果存储对象满足标准，则存储对象从多层存储系统的一层移动到多层存储系统的另一层。

公开(公告)号：US09062046B2

公开(公告)日：2015-06-23

申请号：US13810431

申请日：2011-07-15

Applicant: Sanjay Kumar ,  Rajiv Sharma ,  Robert Zahler ,  Bichismita Sahu ,  Veena R. Agarwal ,  Nishigandha Naik

Inventor： Sanjay Kumar ,  Rajiv Sharma ,  Robert Zahler ,  Bichismita Sahu ,  Veena R. Agarwal ,  Nishigandha Naik

IPC: A61K31/43 ,  C07D471/00 ,  C07D491/00 ,  C07D498/00 ,  C07D513/00 ,  C07D515/00 ,  C07D471/04 ,  A61K31/4745

CPC classification number: C07D471/04 ,  A61K31/4745 ,  Y02A50/411

Abstract: The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammatory diseases and angiogenesis related disorders.

Abstract translation: 本发明涉及取代的咪唑并[4,5-c]喹啉衍生物，式（I）化合物，其中R 1，R 2，R 3，R 4，R 5，R 6和R 7如说明书中所定义，其制备方法 包含式（I）化合物的药物组合物及其在治疗由一种或多种激酶，特别是增殖性疾病或病症如癌症介导的疾病或病症中的用途。 这些化合物也可用于治疗炎性疾病和血管发生相关疾病。

公开(公告)号：US09049034B2

公开(公告)日：2015-06-02

申请号：US13019310

申请日：2011-02-02

Applicant: Manoj Kumar Jain ,  Sanjay Kumar ,  Sumit Kumar ,  Lokesh Chenta

Inventor： Manoj Kumar Jain ,  Sanjay Kumar ,  Sumit Kumar ,  Lokesh Chenta

IPC: G01R31/08 ,  H04L12/18 ,  H04L12/26

CPC classification number: H04L12/1863 ,  H04L43/026

Abstract: Provided is a method of monitoring a multicast flow. An initial multicast flow is characterized as a baseline flow entity. A subsequent multicast flow is compared against the baseline flow entity to identify anomalies between the baseline flow entity and the subsequent multicast flow.

Abstract translation: 提供了一种监视组播流的方法。 初始多播流被表征为基线流实体。 将后续多播流与基线流实体进行比较，以识别基线流实体与后续多播流之间的异常。

公开(公告)号：US08862102B2

公开(公告)日：2014-10-14

申请号：US12906057

申请日：2010-10-15

Applicant: Abhay Karandikar ,  Animesh Kumar ,  Prateek Kapadia ,  Sanjay Kumar ,  Somya Sharma ,  Dhanashree Deval Parakh

Inventor： Abhay Karandikar ,  Animesh Kumar ,  Prateek Kapadia ,  Sanjay Kumar ,  Somya Sharma ,  Dhanashree Deval Parakh

IPC: H04M3/42 ,  H04W4/20 ,  G06Q30/02 ,  H04M7/00 ,  H04L29/08 ,  H04W4/12

CPC classification number: H04M7/0024 ,  G06Q30/02 ,  H04L67/04 ,  H04M3/42348 ,  H04M3/42382 ,  H04M2203/655 ,  H04M2207/18 ,  H04W4/12 ,  H04W4/21

Abstract: A mobile social networking platform including a system and method for cellular communications and accessing services using cellular communications. The system and method enable any mobile device user having a mobile station (MS) with minimal functionality to SMS to access a social network without installing any additional software on the MS. The system and method also enable the mobile user to access Location Based Services even if the network provides location information, without specifically requiring a GPS/GPRS enabled MS.

Abstract translation: 一种移动社交网络平台，包括用于蜂窝通信的系统和方法以及使用蜂窝通信接入服务。 该系统和方法使具有移动站（MS）的任何移动设备用户具有对SMS的最小功能来访问社交网络而不在MS上安装任何附加软件。 即使网络提供位置信息，该系统和方法也使得移动用户能够访问基于位置的服务，而不需要具有GPS / GPRS功能的MS。

公开(公告)号：US08816968B2

公开(公告)日：2014-08-26

申请号：US12903320

申请日：2010-10-13

Applicant: Kamlesh K. Mishra ,  Sanjay Kumar

Inventor： Kamlesh K. Mishra ,  Sanjay Kumar

IPC: G06F3/041

CPC classification number: G09G5/04 ,  G06F1/3218 ,  G06F1/3231 ,  G06F1/3265 ,  G06F3/1438 ,  G06F3/1446 ,  G09G5/02 ,  G09G5/10 ,  G09G2310/0237 ,  G09G2320/0626 ,  G09G2320/066 ,  G09G2320/0666 ,  G09G2330/021 ,  G09G2330/022

Abstract: Reducing energy usage by a monitor includes a map manager between a monitor interface and a processor that divides a display area of a monitor into areas and stores display information in a staging area. The map manager distinguishes an active window selected by a user from the remainder inactive, unselected areas of a display, and further determines a used subset of areas within the active window distinguished from the remainder unused areas as a function of a user preference. Accordingly, the map manager drives the monitor at each of the used area active window areas with the processor display information stored in the staging area at a normal luminance specified by the processor display information, and at each of the remainder unused, inactive and unselected areas of the total display area at a reduced luminance lower than the specified normal luminance.

Abstract translation: 由监视器减少能量使用包括在监视器接口和将监视器的显示区域划分为区域并将显示信息存储在暂存区域中的处理器之间的地图管理器。 地图管理器将用户选择的活动窗口与显示器的其余非活动的，未选择的区域区分开，并且还根据用户偏好确定与剩余未使用区域区分的活动窗口内已使用的区域的已使用子集。 因此，地图管理器以处理器显示信息指定的正常亮度处理存储在分段区域中的处理器显示信息的每个使用区域活动窗口区域驱动监视器，并且在剩余的未使用的，不活动的和未选择的区域 的亮度低于指定的正常亮度。

公开(公告)号：US08671225B2

公开(公告)日：2014-03-11

申请号：US13317009

申请日：2011-10-06

Applicant: Kiran S. Panesar ,  Sanjay Kumar ,  Abdul R. Ismail ,  Philip Lantz

Inventor： Kiran S. Panesar ,  Sanjay Kumar ,  Abdul R. Ismail ,  Philip Lantz

IPC: G06F3/00 ,  G08B13/14

CPC classification number: G06F9/45533 ,  G06F9/4411 ,  G06F9/4413

Abstract: A method for managing data between a virtual machine a bus controller includes transmitting an input output (IO) request from the virtual machine to a service virtual machine that owns the bus controller. According to an alternate embodiment, managing data between a virtual machine and a bus controller includes trapping a register access made by the virtual machine. A schedule is generated to be implemented by the bus controller. Status is returned to the virtual machine via a virtual host controller. Other embodiments are described and claimed.

Abstract translation: 一种用于在虚拟机之间管理数据的方法，总线控制器包括将来自虚拟机的输入输出（IO）请求发送到拥有总线控制器的服务虚拟机。 根据替代实施例，在虚拟机和总线控制器之间管理数据包括捕获由虚拟机进行的寄存器访问。 生成由总线控制器实现的调度。 状态通过虚拟主机控制器返回到虚拟机。 描述和要求保护其他实施例。

公开(公告)号：US20130116248A1

公开(公告)日：2013-05-09

申请号：US13810431

申请日：2011-07-15

Applicant: Sanjay Kumar ,  Rajiv Sharma ,  Robert Zahler ,  Bichismita Sahu ,  Veena R. Agarwal ,  Nishigandha Naik

Inventor： Sanjay Kumar ,  Rajiv Sharma ,  Robert Zahler ,  Bichismita Sahu ,  Veena R. Agarwal ,  Nishigandha Naik

IPC: C07D471/04

CPC classification number: C07D471/04 ,  A61K31/4745 ,  Y02A50/411

Abstract: The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammatory diseases and angiogenesis related disorders.

Abstract translation: 本发明涉及取代的咪唑并[4,5-c]喹啉衍生物，式（I）化合物，其中R 1，R 2，R 3，R 4，R 5，R 6和R 7如说明书中所定义，其制备方法 包含式（I）化合物的药物组合物及其在治疗由一种或多种激酶，特别是增殖性疾病或病症如癌症介导的疾病或病症中的用途。 这些化合物也可用于治疗炎性疾病和血管发生相关疾病。

公开(公告)号：US20120232072A1

公开(公告)日：2012-09-13

申请号：US13508135

申请日：2010-11-04

Applicant: Sanjay Kumar ,  Sivaramakrishnan Hariharan ,  Mandar Bhonde ,  Nilesh Dagia ,  Rajiv Sharma ,  Pallavi Hanmantrao Mane ,  Pramod Bhaskar Kumar

Inventor： Sanjay Kumar ,  Sivaramakrishnan Hariharan ,  Mandar Bhonde ,  Nilesh Dagia ,  Rajiv Sharma ,  Pallavi Hanmantrao Mane ,  Pramod Bhaskar Kumar

IPC: A61K31/437 ,  A61K31/444 ,  A61K31/4709 ,  A61K31/5377 ,  C07D498/04 ,  A61K31/5383 ,  A61K31/506 ,  A61P35/00 ,  A61P35/02 ,  A61P17/06 ,  A61P17/00 ,  A61P17/14 ,  A61P19/04 ,  A61P29/00 ,  A61P1/00 ,  A61P19/02 ,  A61P19/08 ,  A61P19/10 ,  A61P9/10 ,  A61P9/00 ,  A61P25/00 ,  A61P27/02 ,  A61P1/04 ,  A61P21/00 ,  A61P15/00 ,  A61P37/06 ,  A61P11/00 ,  A61P7/00 ,  A61P11/06 ,  C07D471/04

CPC classification number: C07D471/04

Abstract: The present invention relates to compounds of formula (I), wherein Ra, Rb, Rc, Rd, Re and Rf are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases mediated by phosphatidylinositol-3-kinase (PI3K), mammalian target of rapamycin (mTOR), Signal transducer and activator of transcription 3 (STAT 3), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) or a combination thereof particularly in the treatment of cancer and inflammation.

Abstract translation: 本发明涉及式（I）化合物，其中Ra，Rb，Rc，Rd，Re和Rf如说明书中所定义，其制备方法，含有它们的药物组合物及其在治疗由 磷脂酰肌醇-3-激酶（PI3K），雷帕霉素哺乳动物靶（mTOR），信号转导和转录激活因子3（STAT3），肿瘤坏死因子-α（TNF-α），白细胞介素-6（IL-6）或 特别是在治疗癌症和炎症中的组合。